# Usana Health Sciences Inc: filings

USNA · NYSE · CIK 896264 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Jan 3

Pages: [Overview](/companies/usna.md) · [Financials](/companies/usna/financials.md) · [Filings](/companies/usna/filings.md) · [Insiders](/companies/usna/insiders.md)

## Reports and events: 249 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 1129, 8-K 143, 10-Q 53, 144 53, SC 13G/A 35, 5 26, 3 25, 4/A 20, 10-K 18, 11-K 18, DEF 14A 18, DEFA14A 15, UPLOAD 11, SC 13D/A 10, CORRESP 9, SC 13G 7, SCHEDULE 13G/A 7, 8-K/A 5, ARS 5, 3/A 3, S-8 3, 5/A 2, SCHEDULE 13G 2, 10-Q/A 1, 25 1, 8-A12B 1, CERTNYS 1, EFFECT 1, S-3 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-05 | 20:36 ET | [8-K](/filings/0000896264-26-000060.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000896264-26-000060 |
| 2026-08-13 | 18:37 ET | [10-Q](/filings/0000896264-26-000056.md) | Quarterly report, period 2026-07-04 | 0000896264-26-000056 |
| 2026-08-04 | 20:22 ET | [8-K](/filings/0000896264-26-000050.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000896264-26-000050 |
| 2026-05-20 | 20:24 ET | [8-K](/filings/0000896264-26-000036.md) | 5.07 Shareholder vote results | 0000896264-26-000036 |
| 2026-05-12 | 20:35 ET | [10-Q](/filings/0000896264-26-000034.md) | Quarterly report, period 2026-04-04 | 0000896264-26-000034 |
| 2026-05-05 | 20:17 ET | [8-K](/filings/0000896264-26-000030.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000896264-26-000030 |
| 2026-04-07 | 20:50 ET | [DEF 14A](/filings/0000896264-26-000026.md) | Proxy statement, period 2026-01-03 | 0000896264-26-000026 |
| 2026-03-30 | 01:20 ET | [SCHEDULE 13D/A](/filings/0001104659-26-037181.md) | Ownership report, active investor, amended | 0001104659-26-037181 |
| 2026-03-16 | 18:57 ET | [10-K](/filings/0000896264-26-000021.md) | Annual report, period 2026-01-03 | 0000896264-26-000021 |
| 2026-02-18 | 01:33 ET | [8-K](/filings/0000896264-26-000014.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000896264-26-000014 |
| 2026-02-11 | 21:51 ET | [8-K/A](/filings/0000896264-26-000012.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000896264-26-000012 |
| 2026-01-12 | 11:29 ET | [8-K](/filings/0000896264-26-000005.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000896264-26-000005 |
| 2026-01-08 | 14:01 ET | [8-K](/filings/0000896264-26-000002.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000896264-26-000002 |
| 2025-11-05 | 22:11 ET | [10-Q](/filings/0000896264-25-000224.md) | Quarterly report, period 2025-09-27 | 0000896264-25-000224 |
| 2025-10-22 | 20:12 ET | [8-K](/filings/0000896264-25-000213.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000896264-25-000213 |
| 2025-10-09 | 20:10 ET | [8-K](/filings/0000896264-25-000210.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000896264-25-000210 |
| 2025-08-05 | 20:50 ET | [10-Q](/filings/0000896264-25-000205.md) | Quarterly report, period 2025-06-28 | 0000896264-25-000205 |
| 2025-07-22 | 20:06 ET | [8-K](/filings/0000896264-25-000178.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000896264-25-000178 |
| 2025-07-01 | 15:54 ET | [8-K](/filings/0000896264-25-000175.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000896264-25-000175 |
| 2025-05-20 | 22:25 ET | [8-K](/filings/0000896264-25-000144.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events | 0000896264-25-000144 |
| 2025-05-06 | 18:42 ET | [10-Q](/filings/0000896264-25-000126.md) | Quarterly report, period 2025-03-29 | 0000896264-25-000126 |
| 2025-04-22 | 20:06 ET | [8-K](/filings/0000896264-25-000119.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000896264-25-000119 |
| 2025-04-04 | 21:11 ET | [DEF 14A](/filings/0000896264-25-000105.md) | Proxy statement, period 2024-12-28 | 0000896264-25-000105 |
| 2025-03-12 | 19:36 ET | [10-K](/filings/0000896264-25-000092.md) | Annual report, period 2024-12-28 | 0000896264-25-000092 |
| 2025-03-07 | 20:25 ET | [8-K/A](/filings/0000896264-25-000082.md) | 9.01 Financial statements and exhibits | 0000896264-25-000082 |
| 2025-02-25 | 21:11 ET | [8-K](/filings/0000896264-25-000054.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000896264-25-000054 |
| 2024-12-23 | 14:03 ET | [8-K](/filings/0000896264-24-000235.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000896264-24-000235 |
| 2024-11-05 | 17:56 ET | [10-Q](/filings/0000896264-24-000222.md) | Quarterly report, period 2024-09-28 | 0000896264-24-000222 |
| 2024-10-22 | 20:12 ET | [8-K](/filings/0001628280-24-043281.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-043281 |
| 2024-08-06 | 16:42 ET | [10-Q](/filings/0000896264-24-000208.md) | Quarterly report, period 2024-06-29 | 0000896264-24-000208 |
| 2024-07-23 | 20:11 ET | [8-K](/filings/0000896264-24-000180.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000896264-24-000180 |
| 2024-05-07 | 20:01 ET | [8-K](/filings/0000896264-24-000168.md) | 5.07 Shareholder vote results | 0000896264-24-000168 |
| 2024-05-07 | 19:49 ET | [10-Q](/filings/0000896264-24-000165.md) | Quarterly report, period 2024-03-30 | 0000896264-24-000165 |
| 2024-04-30 | 20:08 ET | [8-K](/filings/0000896264-24-000138.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000896264-24-000138 |
| 2024-03-22 | 17:24 ET | [DEF 14A](/filings/0000896264-24-000119.md) | Proxy statement, period 2023-12-30 | 0000896264-24-000119 |
| 2024-02-27 | 21:26 ET | [10-K](/filings/0000896264-24-000093.md) | Annual report, period 2023-12-30 | 0000896264-24-000093 |
| 2024-02-06 | 21:15 ET | [8-K](/filings/0001157523-24-000176.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001157523-24-000176 |
| 2023-11-07 | 19:09 ET | [10-Q](/filings/0000896264-23-000030.md) | Quarterly report, period 2023-09-30 | 0000896264-23-000030 |
| 2023-10-24 | 20:05 ET | [8-K](/filings/0001157523-23-001529.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001157523-23-001529 |
| 2023-08-08 | 19:39 ET | [10-Q](/filings/0000896264-23-000024.md) | Quarterly report, period 2023-07-01 | 0000896264-23-000024 |
| 2023-07-25 | 20:05 ET | [8-K](/filings/0001157523-23-001145.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001157523-23-001145 |
| 2023-05-12 | 20:15 ET | [8-K/A](/filings/0001157523-23-000832.md) | 5.02 Departure or appointment of officers or directors | 0001157523-23-000832 |
| 2023-05-11 | 20:15 ET | [8-K](/filings/0001157523-23-000825.md) | 5.07 Shareholder vote results | 0001157523-23-000825 |
| 2023-05-09 | 17:37 ET | [10-Q](/filings/0000896264-23-000010.md) | Quarterly report, period 2023-04-01 | 0000896264-23-000010 |
| 2023-05-04 | 12:15 ET | [8-K](/filings/0001157523-23-000729.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001157523-23-000729 |
| 2023-04-25 | 20:06 ET | [8-K](/filings/0001157523-23-000608.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001157523-23-000608 |
| 2023-03-31 | 20:23 ET | [DEF 14A](/filings/0001140361-23-015363.md) | Proxy statement | 0001140361-23-015363 |
| 2023-02-28 | 19:34 ET | [10-K](/filings/0000896264-23-000004.md) | Annual report, period 2022-12-31 | 0000896264-23-000004 |
| 2023-02-13 | 21:30 ET | [8-K](/filings/0001157523-23-000267.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001157523-23-000267 |
| 2023-02-07 | 21:07 ET | [8-K](/filings/0001157523-23-000197.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001157523-23-000197 |

Page 1 of 5. [Older](/companies/usna/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:59 ET. No prices; not investment advice.